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A portable SERS method for the determination of
uric acid using a paper-based substrate and
multivariate curve resolution
Javier E. L. Villa and Ronei J. Poppi*
This paper presents a portable quantitative method for the on-site determination of uric acid in urine
using surface-enhanced Raman spectroscopy (SERS) and gold nanoparticle-coated paper as a substrate.
A procedure was developed for the rapid preparation of cost-effective SERS substrates that enabled the
adequate control of a homogeneous active area and the use of small quantities of gold nanoparticles per
substrate. The standard addition method and multivariate curve resolution-alternating least squares
(MCR-ALS) were applied to compensate for the matrix effect and to address overlapping bands between
uric acid and interference SERS spectra. The proposed methodology demonstrated better performance
than conventional univariate methods (in terms of linearity, accuracy and precision), a wide linear range
(0–3.5 mmol L−1) and an adequate limit of detection (0.11 mmol L−1). For the first time, a portable SERS
method coupled with chemometrics was developed for the routine analysis of uric acid at clinically rele-
vant concentrations with minimal sample preparation and easy extension for the on-site determination of
other biomarkers in complex sample matrices.
1. Introduction
Uric acid is the end product of the catabolization of purine
nucleotides and is considered to be an important biomarker
in urine and serum.1 Previous studies have shown that high
uric acid concentrations in these biological fluids can be
associated with renal diseases2 and preeclampsia, a hyper-
tensive disorder that occurs during pregnancy and is the
primary cause of maternal morbidity and mortality worldwide
(more than 50 000 deaths per year), mainly in developing
countries.1,3 Currently, there is no single reliable, cost-effective
screening test for preeclampsia and no well-established
measures for primary prevention. However, the monitoring,
inter alia, of uric acid levels in the urine and serum can ident-
ify hypertensive pregnant women with a propensity toward
superimposed preeclampsia.4,5
The most widely employed methods for uric acid determi-
nation in urine and serum are limited by the use of expensive
enzymes and the time-consuming nature of assay-based
tests.6–9 Methodologies based on liquid chromatography and
capillary electrophoresis have also been reported.10,11 However,
the use of organic solvents, the associated laborious sample
preparation and extended measurement durations make the
analysis unsuitable for rapid and routine uric acid monitoring.
Raman spectroscopy is a powerful technique that has
shown progress in applications because it can provide chemi-
cal and structural information with minimal sample prepa-
ration.12 Moreover, in recent years, the development of
portable Raman spectrometers introduced the possibility of
rapid on-site detection in a wide variety of sample types.13–16
The low efficiency of inelastic scattering restricted the use of
Raman spectroscopy to relatively high concentration analyses;
nevertheless, surface-enhanced Raman spectroscopy (SERS) is
an interesting alternative to overcome this limitation. SERS
can dramatically increase the efficiency of Raman scattering
through a combination of electromagnetic and chemical con-
tributions when the target molecule (analyte) is attached to
the surface of metallic nanostructures (typically made of gold
or silver).17,18 The characteristics of these metallic nano-
structures play an important role in their application and par-
ticularly quantitative analytical methods for remote and
routine analysis require (in the first instance) inexpensive,
reproducible and sensitive SERS substrates.19
The literature reports several applications of SERS methods
for the highly sensitive detection of analytes in aqueous solu-
tion even at the single-molecule level.20–23 However, these
methods may not be extended to perform a quantitative analy-
sis in real samples because unpredictable changes from exter-
nal non-controllable parameters (sample matrix) can occur;
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these require an appropriate strategy to address this effect.
Additionally, depending on the type of matrix analyzed, over-
lapping bands can also be an important limitation during the
development of quantitative SERS methods due to interfer-
ences present in the samples.24,25 The standard addition
method and multivariate curve resolution-alternating least
squares (MCR-ALS) have been successfully employed in
chromatography to overcome similar problems of the matrix
effect and overlapping bands;26–28 however, their use is rare in
quantitative SERS analysis.
Therefore, to be considered an efficient alternative to con-
ventional analytical methods, a SERS-based approach should
be rapid, reproducible and capable of performing remote uric
acid determination in urine at clinically relevant concen-
trations (≥0.4 mmol L−1) even in the presence of interferences.
To achieve this goal, the primary objectives of this work were
(i) to develop a rapid procedure for the preparation of cost-
effective SERS substrates, (ii) to apply a standard addition
method to compensate for the matrix effect in urine analysis,
(iii) to build a calibration curve for uric acid quantification in
the presence of interferences using MCR-ALS, and (iv) to vali-
date a MCR-ALS-based method for the determination of uric
acid in synthetic urine.
2. Algorithm and data analysis
Multivariate curve resolution is a generic denomination of a
family of methods based on the bilinear decomposition of a
matrix D in scores (C) and loadings (S) containing information
about samples and variables, respectively (eqn (1)).29
D ¼ CST þ E ð1Þ
The MCR-ALS algorithm can be summarized in three steps.
First, C is estimated from D and an initial S, which is esti-
mated using PURE,30 SIMPLISMA31 or from known data (eqn
(2)). The C matrix is then employed for a new estimation of S
using eqn (3).32
Ĉ ¼ DðSTÞþ ð2Þ
ŜT ¼ CþD ð3Þ
Finally, the calculations are repeated several times until the
error reaches a minimal value (eqn (4)).
Error ¼ min k D CST k ð4Þ
To perform a standard addition analysis via MCR-ALS, the
spectroscopic data are arranged in a matrix D (r × c) with the
levels of addition in rows and intensities in columns (Fig. 1).
MCR-ALS decomposes matrix D using the initial estimate of
the spectroscopic profiles (first and last row from matrix D).
For m species, concentration profiles are described using
matrix C (r × m); spectral contributions are given in matrix ST
(m × c), and E (r × c) is the matrix of residuals that are not
explained.
In this work, MCR calculations were performed using
MatLab in conjunction with MCR-ALS Toolbox 2.0.33
3. Experimental section
3.1 Instrumentation
A Mira M-1 portable Raman spectrometer (Metrohm, Herisau,
Switzerland) equipped with a 785 nm source and a maximum
laser output power of 75 mW was employed to obtain the
spectra. This enabled remote sampling (on-site), high sensi-
tivity and rapid data collection. The average spectral resolution
was between 12 and 14 cm−1, and the exposure time was in the
range of 1.5–2 s for all measurements. The spectra were
recorded in a spectral range of 400 to 1800 cm−1.
UV-visible absorption and field emission-scanning electron
microscopy (FE-SEM) investigations were performed using a
Varian Cary probe 50 UV-Vis spectrophotometer and a FEI
Quanta FEG 250 FE-SEM, respectively.
3.2 Chemicals
All solutions were prepared with deionized water (electrical
resistivity of 18.2 MΩ cm) provided in a Milli-Q1 Ultrapure
Water Purification System (Millipore, Brussels, Belgium).
Chloroauric acid (HAuCl4, 30% mm
−1), anhydrous sodium
citrate (Na3C6H5O7), bovine albumin, citric acid, creatinine,
urea and uric acid were purchased from Sigma-Aldrich (Sao
Paulo, SP, Brazil). Sodium chloride, sodium dihydrogen phos-
phate and potassium chloride were purchased from Merck
(Darmstadt, Germany). Laser printer paper with 70 g m−2 pur-
chased from Chamex (Sao Paulo, SP, Brazil) was used to
prepare all the SERS substrates.
3.3 Preparation of gold nanoparticles and paper-based SERS
substrates
In this work, gold nanoparticles (GNPs) were selected instead
of silver nanoparticles due to their higher chemical stability
and facile synthesis. The synthesis of colloidal GNPs was
Fig. 1 MCR-ALS arrangement for the standard addition method (Cs is
the analyte concentration in the sample).
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based on the Turkevich method because it provides a rapid,
simple and reproducible method to obtain homogeneous
GNPs.34 Briefly, an aliquot of 40 µL HAuCl4 solution (30%,
mm−1) was pipetted into approximately 100 mL of deionized
water and heated under constant stirring. After achieving the
boiling point, 1.4 mL of anhydrous sodium citrate solution
(2%, mv−1) was added to the mixture under magnetic stirring
and, after five minutes, the agitation was interrupted and col-
loidal GNPs were cooled to room temperature. The GNPs were
centrifuged at 3000 rpm for 15 min; 90% of the supernatant
was then discarded.
The SERS substrates used in this work were prepared using
the proposed system shown in Fig. 2. This system consists of
two Teflon templates, one of which has six circular holes
(0.4 cm in diameter) used for controlling the active area of the
SERS substrates. Printing paper was placed between the two
Teflon templates, and aliquots of 20 µL of GNPs were added.
The system was then placed in an oven at 80 °C for approxi-
mately 80 min. Finally, the SERS substrates obtained were
individually cut and coated on pieces of glass measuring 1 ×
1 cm2.
3.4 Quantitative determination of uric acid in synthetic urine
Synthetic urine with and without uric acid was prepared taking
into account the majority components (potential SERS inter-
ferences) of the real urine matrix of a healthy person.35,36
Thus, to obtain approximately 1 L of synthetic urine, 10 g of
urea, 5.2 g of NaCl, 4.5 g KCl, 4.8 g of NaH2PO4, 0.4 g of citric
acid, 0.8 g of creatinine and 50 mg of albumin were mixed
with 900 mL of deionized water. Then, the pH was adjusted to
6.0 with diluted NaOH or HCl, and the volume was sup-
plemented with deionized water to obtain a specific gravity of
approximately 1.1 g cm−3.
Normal Raman spectroscopy was tested for uric acid con-
centrations at 2, 5 and 10 mM and no Raman spectra were
observed, thereby indicating that SERS should be used for uric
acid quantification at these concentration levels. To minimize
the duration of sample preparation, the analyses were per-
formed via simple dilution and, after several tests, a sample
dilution of 1% was selected. The uric acid SERS spectra experi-
enced an increasing intensification with the time of incu-
bation tested (from 5 to 30 min). However, after the incubation
time of 15 min there was no significant variation in the uric
acid SERS spectra. Thus, the SERS substrates were dipped for
15 min and dried prior to analysis. All experiments were
carried out in triplicate.
4. Results and discussion
4.1 Characterization of gold nanoparticles and SERS
substrate preparation
Colloidal gold nanoparticles (GNPs) were characterized via
UV-Vis spectroscopy and FE-SEM microscopy; these studies
enabled the calculation of the maximum absorption wave-
length (534 nm) and the mean particle diameter (47 ± 9 nm, N
= 80). The results obtained are in agreement with the expected
correlation between the mean particle diameter and maximum
absorption wavelength reported by Njoki et al.37 The particle
size is adequate for SERS analysis based on studies performed
by Hong et al. and Bell et al. indicating that particle diameters
of approximately 46 and 50 nm, respectively, may provide an
optimum SERS signal intensification.38,39
Previously described procedures for the preparation of
SERS substrates based on GNP-coated paper involved dipping
a piece of paper into a GNP solution (10 mL per substrate) for
a relatively long duration (at least 24 h).40–42
To improve this procedure, a simple system (Fig. 2) was
employed. The type of paper used and the preconcentration
level of colloidal GNPs prior to deposition are two important
parameters in obtaining an efficient and reproducible SERS
substrate in the proposed procedure. This case considers the
higher number of fibers per area compared with filter paper
and the possibility of minimizing the amount of GNPs added
without the loss of intensity; thus, printing paper and a 10-
fold preconcentration level prior to GNP deposition were
selected to promote the agglomeration of the GNPs (“hot
spots” generation) on the paper surface.43 The principal advan-
tages of the proposed procedure include better control of the
active area, lower numbers of GNPs used per substrate (0.2 mL
of GNPs), a reduction in the preparation time (80 min) and
easy handling after GNP deposition. The FE-SEM image of
GNPs and SERS substrates after GNP deposition shown in
Fig. 3 demonstrates that a homogeneous and densely packed
GNP deposition over printing paper fibers was achieved to
provide a high number of SERS hot spots and to generate a
SERS spectra enhancement of molecules near the active
surface.
4.2 Considerations regarding the matrix effect and
overlapping bands
A study of synthetic urine was performed to develop a quanti-
tative method to quantify uric acid in a complex sample
matrix. Fig. 4A shows the SERS spectra obtained for uric acid
Fig. 2 Proposed procedure for the rapid preparation of paper-based
SERS substrates.
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in aqueous solution and in synthetic urine matrix. The inten-
sity of several bands of uric acid SERS spectra decreases in the
presence of a synthetic urine matrix, primarily at 493 cm−1
(C–N–C ring vibrations), 633 cm−1 (skeletal ring deformation),
1016 cm−1 (ring vibration), 1130 cm−1 (mixed vibrations) and
1550 cm−1 (C–N stretching). This can be explained by the com-
petition between uric acid and non-targeted compounds in the
matrix, which can limit the qualitative and quantitative ana-
lyses, primarily for a complex sample matrix.25,44 However, the
intensification of the bands at 725 cm−1 (N–H bending) and
1398 cm−1 (mixed vibration) was observed due to the contri-
bution of compounds present in the synthetic urine matrix on
the SERS spectra. These observations demonstrate that an
external calibration in aqueous solution is not adequate for
quantitative SERS analysis in a synthetic urine matrix; this
could apply to the quantification of other analytes in complex
sample matrices because the target molecule is not isolated in
a real sample. Additionally, Fig. 4B shows that in addition to
“signal suppression” due to the matrix effect, overlapping
bands between uric acid and interferences can be observed (as
expected). These interferences for the SERS spectra of uric acid
may arise from the substrate background or chemical com-
pounds with similar chemical functions such as creatinine
and urea (which are normally present in the urine at higher
concentrations than uric acid). Thus, a sample preparation (via
dilution) cannot be used to solve this problem.
4.3 MCR-ALS and addition standard method
Synthetic urine was spiked with known concentrations of uric
acid, and SERS spectra were obtained. Weighted least squares
(WLS)45 was employed in data preprocessing for baseline cor-
rection, and MCR-ALS decomposed the matrix (D) into its pure
response profiles using an initial estimate and assuming that
the experimental data followed a linear behavior. Singular
value decomposition (SVD) was used to identify the number of
significant contributions to the data variance. In this case, two
significant contributions (from uric acid and interferences)
were identified. To overcome the possibility of rotational ambi-
guity in the MCR-ALS analysis, a non-negativity constraint for
concentrations was employed. The fast non-negative least
squares (FNNLS) algorithm was selected as an interactive
method with a convergence value of 0.1%.
MCR-ALS recovered the individual SERS spectra (matrix ST)
from the mixed SERS spectra of uric acid and interferences,
thereby enabling the analysis of this complex matrix without
the necessity to identify and include the interferences in the
model (second order advantage).
The recovered SERS spectrum of uric acid was compared
with that obtained in aqueous solution (Fig. 5), showing good
similarity (correlation of 93%) and confirming that a chemical
interpretation of uric acid spectra can be performed even with
overlapping bands due to chemical interferences.
MCR-ALS was also used to build a pseudo-univariate curve
(Fig. 6A) using recovery values from the C matrix relative to
uric acid additions. A wide range of uric acid concentrations
was added to the synthetic urine (0–25 mmol L−1) to obtain a
Fig. 3 FE-SEM microscopy of GNPs (A) and GNP-coated paper (B).
Fig. 4 Matrix effect evaluation for uric acid (UA) in aqueous solution
and in synthetic urine (SU) medium (A) and the effect of various uric acid
additions to synthetic urine (B).
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linear working range for quantifying uric acid. A correlation
coefficient (R2) of 0.989 was found in the range of 0 to
3.5 mmol L−1; linearity was assessed in an analysis of variance
(ANOVA) and indicated no significant linearity deviation (P <
0.05). Additionally, the standard addition curve used to deter-
mine uric acid (0.5 mmol L−1) in synthetic urine is presented
in Fig. 6B.
4.4 Analytical method performance
The applicability of the proposed method was validated by
assessing the accuracy and precision at three uric acid addition
levels (Table 1). There were no significant differences between
the expected and calculated concentrations using the proposed
method in all the studied levels (Student’s t-test at a 95% con-
fidence level). The relative error (Er) was in the range of 3–9%,
thereby providing adequate accuracy for uric acid determi-
nation (less than 17%) according to the recommendations of
the Clinical Laboratory Improvement Amendments (CLIA).46
Precision, expressed as the relative standard deviation (RSD),
varied between 8.7% and 14.8%. These values include the
possible variations in inter and across substrates (substrate
homogeneity) as well as from batch to batch. Moreover, the
limit of detection (LOD) and quantification (LOQ) were 0.11
and 0.36 mmol L−1,47 respectively, thereby demonstrating uric
acid determinations at clinically relevant concentrations
(≥0.4 mmol L−1) because uric acid levels above 0.4 mmol L−1
in the urine and serum can be associated with severe hyper-
tension and proteinuria, which could lead to a diagnosis of
preeclampsia.5,48
A univariate analysis was performed at 493 cm−1 (the least
overlapped band); notably, similar results to those reported for
the electrochemical SERS detection of uric acid were found.48
However, a reduced correlation coefficient (R2, 0.960) and
reduced precision (RSD, 11–20%) and accuracy (Er, 13–16%)
were noted compared with the MCR-ALS approach. This is in
agreement with previous studies, thereby demonstrating the
advantages of multivariate over conventional univariate
methods in quantitative SERS analysis.44,49 Thus, in addition
to the potential for a chemical interpretation of pure SERS
spectra, an MCR-ALS-based method can provide better per-
formance than a conventional univariate method for uric acid
determination in synthetic urine and may be easily extended
for the determination of other biomarkers even in the pres-
ence of interferences. Furthermore, this opens the possibility
of using the proposed method for rapid and on-site monitor-
ing of uric acid in the urine of pregnant women, which may
lead to early preeclampsia diagnosis.
5. Conclusions
In summary, GNP-coated paper substrates prepared in the pro-
posed procedure result in cost-effective SERS substrates that
can be applied for the on-site determination of uric acid with
minimum sample preparation. Considerations about the
matrix effect demonstrated that an external calibration is not
Fig. 5 Comparison between MCR-ALS recovered and expected SERS
spectra of uric acid (UA).
Fig. 6 Linear range for uric acid determinations in synthetic urine (A)
and the standard addition curve for the determination of uric acid
0.5 mmol L−1 (B).
Table 1 Addition and recovery experiment to evaluate accuracy and






(%) Er (%) RSD (%)
Level 1 (0.5 mmol L−1) 0.47 ± 0.07 94 −6 14.8
Level 2 (1 mmol L−1) 1.03 ± 0.10 103 +3 9.7
Level 3 (2 mmol L−1) 2.18 ± 0.19 109 +9 8.7
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adequate for quantitative analysis in synthetic urine and that
the standard addition method should be used to overcome
this problem. The MCR-ALS approach was used to solve the
overlapping bands of uric acid and interference SERS spectra
as well as presenting adequate performance (accuracy, pre-
cision and detection limit) for controlling uric acid. This is the
first time that a method based on SERS-coupled chemometrics
was employed for the remote determination of uric acid at
clinically relevant concentrations. This method could be
implemented for the rapid preliminary testing of preeclampsia
and the determination of other biomarkers in complex sample
matrices.
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